Qiagen Acquires Eppendorf's Reagent Business

A co-development and co-marketing alliance has been announced by Qiagen N.V. (Venlo, The Netherlands) and Eppendorf (Hamburg, Germany), whereby Qiagen has acquired the nucleic acid sample preparation kit and polymerase chain reaction (PCR) reagent business of Eppendorf. Financial terms were not disclosed.

The alliance is designed to link two strong brands and product lines in the industry to ensure the highest compatibility of their products, which target research, applied testing, and molecular diagnostics.

Eppendorf's reagent business includes the 5-Prime nucleic acid sample preparation and PCR reagent product lines and related intellectual property. The acquired assets represent an attractive portfolio of preanalytic and nucleic acid amplification consumables and also a promising pipeline of technologies for nucleic acid handling, separation, purification, and amplification.

Qiagen has developed a comprehensive portfolio of proprietary, consumable products for nucleic acid and protein separation, purification and handling, as well as automated instrumentation. Through the alliance, the two companies intend to focus on improving biologic sample management and analysis. They believe the availability of combined and optimized products should create significant benefits for customers in research, applied testing, and molecular diagnostics.

"Functionalizing Eppendorf solutions with Qiagen's biological and chemical preanalytical capabilities will allow both partners to take ease-of-use and capabilities of molecular biology methods to new levels,” said Peer Schatz, CEO of Qiagen.



Related Links:
Qiagen
Eppendorf